Deal overview
| Target | VERONA PHARMA PLC |
|---|---|
| Bidder | MERCK & CO INC |
| Price | £80.00 Full version or £25.00 Light version |
| Publication Date | Jul 09, 2025 |
| Abstract | On 9 July 2025, the quoted US-based pharmaceutical company Merck & Co Inc. ("Merck") announced a cash offer, by way of a scheme of arrangement, for the UK headquartered, Nasdaq-quoted biopharmaceutical company focused on respiratory diseases Verona Pharma plc ("Verona Pharma”). Merck would pay US$ 107 per American Depository Share ("ADS"), for a total transaction value ... |
| Number of pages (Full version) | 8 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2025 M&A Monitor Limited
